Mineralocorticoid receptor antagonists do not block rapid ERK activation by aldosterone.

Biochem Biophys Res Commun

Department of Clinical Pharmacology, Faculty of Clinical Medicine Mannheim, University of Heidelberg, 68167 Mannheim, Germany.

Published: May 2004

Aldosterone can elicit rapid nongenomic effects both in vivo and in vitro, often mediated by signal transduction cascades. However, it is not understood how these rapid effects are initiated. In this study we show that aldosterone leads to rapid activation of mitogen activated protein kinases ERK1/2 in the cortical collecting duct cell line M-1. Inhibitors of transcription and translation could not block this activation, which suggests an extranuclear (nongenomic) mechanism. Although it is known that M-1 cells do not contain a transcriptionally functional MR, it is not known whether a closely related protein still could mediate the effects, or an unrelated nonclassic receptor. To test this hypothesis, the effects of four classical mineralocorticoid receptor antagonists were studied. None of the compounds could block the response to aldosterone. Altogether, the data suggest that rapid aldosterone effects in M-1 cells are initiated by a receptor different from the classical mineralocorticoid receptor.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2004.04.026DOI Listing

Publication Analysis

Top Keywords

mineralocorticoid receptor
12
receptor antagonists
8
m-1 cells
8
classical mineralocorticoid
8
rapid
5
aldosterone
5
effects
5
antagonists block
4
block rapid
4
rapid erk
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!